Woodson Smelser, MD
Urology · Saint Louis, MONPI 1528453990
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (39.0%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 26 manufacturers reported payments, led by Johnson & Johnson at 24.6% of the total. 2025 is the largest year on record at $11,890, more than ten times the $353 reported in 2021. Among urology clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 96 payments — averaging $201.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$5K
- Intuitive Surgical$4K
- Janssen Scientific Affairs, LLC$3K
- Boston Scientific$1K
- Ferring Pharmaceuticals Inc.$800
- Bayer$790
- plus $4K from 20 others
What the payments were for
- Consulting fees$7,34438%
- Speaking & faculty fees$2,00010%
- Travel & lodging$4572%
- Food & beverage$7,54539%
- Education$2,00010%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 14 | $4,757 |
| Intuitive Surgical | 6 | $4,431 |
| Janssen Scientific Affairs, LLC | 5 | $3,440 |
| Boston Scientific | 14 | $1,447 |
| Ferring Pharmaceuticals Inc. | 1 | $800 |
| Bayer | 8 | $790 |
| Teleflex LLC | 7 | $625 |
| Urogen Pharma, Inc. | 6 | $593 |
| Photocure Inc | 2 | $327 |
| Calyxo, Inc. | 2 | $322 |
| Procept Biorobotics Corporation | 4 | $271 |
| Antares Pharma, Inc. | 2 | $247 |
| Histosonics, Inc. | 1 | $194 |
| Angiodynamics, Inc. | 1 | $157 |
| Baxter Healthcare | 2 | $138 |
| Integra Lifesciences Corporation | 1 | $129 |
| Myovant Sciences Inc. | 1 | $108 |
| Innovation Technologies Inc | 1 | $95 |
| Medtronic | 2 | $88 |
| AbbVie | 5 | $80 |
| KARL Storz Endoscopy-america | 1 | $78 |
| Merck | 3 | $73 |
| Ambu Inc. | 2 | $66 |
| Astellas Pharma US Inc | 3 | $53 |
| Pfizer | 1 | $18 |
| Tolmar, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$4,376
- ADSTILADRIN$800
- Erleada$761
- Nubeqa$540
- JELMYTO$422
- INTEGRA$387
- LithoVue$368
- UroLift$338
- Cysview$327
- CVAC Aspiration System$322
- XYOSTED$247
- AKEEGA$241
- Barrigel$192
- rezum Generator$179
- SpaceOAR VUE System - 10mL$170
- Nanoknife$157
- Xofigo$149
- GENERAL ERECTILE DYSFUNCTION$134
- AquaBeam Robotic System$129
- INTEGRA DERMAL REGENERATION TEMPLATE$129
How this compares
$19,345 in reported general payments places this provider in the 90th percentile of 250 urology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| GemtesaVibegron | 15 | $8,146 |
| MyrbetriqMirabegron | 11 | $5,634 |
| Finasteride | 208 | $1,812 |
| Tamsulosin Hcl | 207 | $1,662 |
| Oxybutynin Chloride ErOxybutynin Chloride | 63 | $786 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 59 | $570 |
| Oxycodone Hcl | 49 | $118 |
| Ciprofloxacin Hcl | 25 | $89 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 22 | $60 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $53 | $5,63411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 250 urology providers in Missouri.
Other urology in Saint Louis
- Travis BullockSaint Louis$201K
- Michael JohnsonSaint Louis$160K
- Gurdarshan SandhuSaint Louis$101K
- Gregory McLennanSaint Louis$89K
- Gerald AndrioleSaint Louis$64K
- Charles JonesSaint Louis$55K
- Meredith MetcalfSaint Louis$26K
- Maung Htein ThuSaint Louis$22K
- Alexander ChowSaint Louis$20K
- Jonathan WeeseSaint Louis$19K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.